GB2329583A - Use of tea-tree oil for prophylaxis against cystitis - Google Patents

Use of tea-tree oil for prophylaxis against cystitis Download PDF

Info

Publication number
GB2329583A
GB2329583A GB9720263A GB9720263A GB2329583A GB 2329583 A GB2329583 A GB 2329583A GB 9720263 A GB9720263 A GB 9720263A GB 9720263 A GB9720263 A GB 9720263A GB 2329583 A GB2329583 A GB 2329583A
Authority
GB
United Kingdom
Prior art keywords
tea
use according
carrier
tree oil
cystitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9720263A
Other versions
GB9720263D0 (en
Inventor
Marilyn Rydstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB9720263A priority Critical patent/GB2329583A/en
Publication of GB9720263D0 publication Critical patent/GB9720263D0/en
Publication of GB2329583A publication Critical patent/GB2329583A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Tea-tree oil may be used in the manufacture of a medicament for prophylactic application to the female genito-urinary area for the prevention of cystitis. The oil may be formulated as a cream, ointment or lotion, or may be incorporated in a carrier. The carrier may be of textile material, or may be rigid enough for insertion into the entrance to the vagina so covering the urethra.

Description

PROPHYLAXIS AGAINST CYSTITIS The present invention relates to the use of a novel agent for prophylaxis against cystitis in women.
Cystitis is due to infection of the urinary system with bacteria, commonly E Coli or Kle6siella, or with a mixture of organisms in which these bacteria predominate. It affects women much more frequently than men.
Coliform bacteria are a normal constituent of the healthy human digestive system, and their presence elsewhere may be taken as an indication of contamination by sewage.
Normally they are not regarded in themselves as pathogenic and do not call for antiseptic measures. However cystitis may be caused when such bacteria reach the normally germ-free urethra.
The female genital area is highly sensitive, and care is necessary to avoid bringing into contact with it any substance, which may act as an irritant - the medical profession advises that even bath salts and perfumed soaps are to be avoided. This sensitivity precludes the use of common effective antiseptic or anti-bacterial agents.
I have now found that tea-tree oil, which is distilled from the leaves of Affielatelca nlrenlifolicr, is particularly effective as an anti-bacterial agent against F. Coli and Kiebsiella, and can prevent infection of the female urethra by these germs. It appears also to be virtually non-irritant, and has the further advantages that it is nowadays easily available and relatively inexpensive. The tea-tree oil is incorporated in a suitable carrier for topical application, with the addition of a diluent where appropriate.
Since the spread of bacteria to the urethra by sexual intercourse is a main cause of cystitis it is essential that application takes place within a few minutes before, or preferably within a few minutes after, intercourse, along with other normal hygiene routines.
The oil may be made up as a cream, ointment or lotion, or incorporated in a carrier, together with a diluent, if required, and optionally with additional active constituents, for example a deodorant. If it is to be used before intercourse a lubricant may preferably also be incorporated.
If a carrier is used it may be of soft textile material, such as lint, surgical gauze or cotton wool, or it may be thin and elongated, and sufficiently rigid for insertion into the entrance to the vagina, so covering the entrance to the urethra.

Claims (6)

1. Use of tea-tree oil for the manufacture of a medicament for prophylactic application to the female genito-urinary area for the prevention of cystitis.
2. Use according to claim 1 in which the tea-tree oil is incorporated into a cream, ointment or lotion.
3. Use according to claim 1 in which the tea-tree oil is incorporated in a carrier.
4. Use according to claim 3 in which the carrier is a pad of textile material.
5. Use according to claim 3 in which the carrier is thin and elongated, and of sufficient rigidity to enable it to be inserted into the urethra.
6. Use according to any of claims 3 to 5 in which the ca-r:e- additionally contains a lubricant or a deodorant.
6. Use according to any of claims 3 to 5 in which the carrier additionally contains a lubricant or a deodorant.
Amendments to the claims have been filed as follows CLAIMS 1. Use of tea-tree oil for the manufacture of a medicament for prophylactic application to the female genito-unnary area for the prevelition of cystitis.
2. Use according to claim 1 in which the tea-tree oil is incorporated into a cream, ointment or lotion.
Use according to claim 1 in which the tea-tree oil is incorpor ted in a carrier.
4. Use according to claim 3 in which the carrier is a pad ot textile material.
Use according to claim 3 in whicl! the carrier is thin end elongated, and of sufficient rigidity to enable it to be inserted into the vagina, so covering tbe urethra.
GB9720263A 1997-09-25 1997-09-25 Use of tea-tree oil for prophylaxis against cystitis Withdrawn GB2329583A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9720263A GB2329583A (en) 1997-09-25 1997-09-25 Use of tea-tree oil for prophylaxis against cystitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9720263A GB2329583A (en) 1997-09-25 1997-09-25 Use of tea-tree oil for prophylaxis against cystitis

Publications (2)

Publication Number Publication Date
GB9720263D0 GB9720263D0 (en) 1997-11-26
GB2329583A true GB2329583A (en) 1999-03-31

Family

ID=10819538

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9720263A Withdrawn GB2329583A (en) 1997-09-25 1997-09-25 Use of tea-tree oil for prophylaxis against cystitis

Country Status (1)

Country Link
GB (1) GB2329583A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007007318A1 (en) 2007-02-14 2008-08-21 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Coating composition for bioactive textile materials, useful e.g. for producing wound dressings, comprises layer-forming inorganic nanoparticulate sol and active component, e.g. natural oil

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1000036A7 (en) * 1986-03-27 1987-11-24 Lampugnani Spa PROCESS FOR OBTAINING AN EXTRACT standardized PALM FRUIT WITH PHARMACEUTICAL ACTIVITY.
GB2257629A (en) * 1990-01-19 1993-01-20 Aamann Christensen Niels Erik Udder or teat care substance with mastitis-preventing effect
WO1994028895A2 (en) * 1993-06-13 1994-12-22 Juergens Uwe R Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1000036A7 (en) * 1986-03-27 1987-11-24 Lampugnani Spa PROCESS FOR OBTAINING AN EXTRACT standardized PALM FRUIT WITH PHARMACEUTICAL ACTIVITY.
GB2257629A (en) * 1990-01-19 1993-01-20 Aamann Christensen Niels Erik Udder or teat care substance with mastitis-preventing effect
WO1994028895A2 (en) * 1993-06-13 1994-12-22 Juergens Uwe R Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WPI Abstract Accession No 87-348808 & BE 1000036 (LAMPUGNANI) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007007318A1 (en) 2007-02-14 2008-08-21 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Coating composition for bioactive textile materials, useful e.g. for producing wound dressings, comprises layer-forming inorganic nanoparticulate sol and active component, e.g. natural oil

Also Published As

Publication number Publication date
GB9720263D0 (en) 1997-11-26

Similar Documents

Publication Publication Date Title
Butler et al. Evaluation of polymyxin catheter lubricant and impregnated catheters
US9314482B2 (en) Methods and compositions for promoting wound healing
DE69515468D1 (en) DISINFECTANT OR ANTISEPTIC COMPOSITION CONTAINING AT LEAST ONE TERPENIC ALCOHOL AND AT LEAST ONE BACTERICIDAL, ACIDIC, SURFACE-ACTIVE ACTIVE SUBSTANCE, AND THEIR USE
US5320838A (en) Protectant for irritated skin containing polyethyleneglycols, polyvinylether salt anhydride and polyvinylpyrrolidone
US20040208842A1 (en) Antimicrobial cleansing compositions and methods of use
RS51154B (en) Pharmaceutical formulations containing low cocentrations of peroxide for treating or preventing vaginal infections
US20060193822A1 (en) Antiseptic spermicidal composition and means for its application
Cinberg Postmenopausal pruritus vulvae
Sawada et al. Treatment of dermal depth burn wounds with an antimicrobial agent-releasing silicone gel sheet
AU778161B2 (en) Hop acids used to inhibit staphylococcus aureus
GB2329583A (en) Use of tea-tree oil for prophylaxis against cystitis
Pillsbury et al. Bacterial Flora of the Normal Skin: Report on the Effect of Various Ointments and Solutions, With Comments on the Clinical Significance of This Study
ARVAN et al. A case report of total knee arthroplasty infected by Pasteurella multocida.
Hack Malodorous wounds—taking the patient's perspective into account
US3812250A (en) Antifungal suppository and method of treating fungus infestations
August Cutaneous necrosis due to cetrimide application.
Tansupasiri et al. Satisfaction and tolerability of combination of lactoserum and lactic acid on the external genitalia in Thai women
RU2286799C1 (en) Method for preventing inflammatory diseases of female genital organs
Birkenstock Surgical sepsis
Janssens et al. Tinidazole in the prevention of post-operative wound infection after hysterectomy
CN1135978C (en) Ointment for moistening and relaxing sexual function
Paulson Full body showerwash Efficacy evaluation of a 4% chlorhexidine gluconate
Kilroy Feminine hygiene products—issues and answers
COTLAR et al. An iodophor for preoperative skin preparation
Lowsley et al. Urolocide, a new skin antiseptic and disinfectant for instruments

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)